Doctor of Medicine, Chief Physician in the Interventional Therapy Department, Peking University Cancer Hospital. Senior Visiting Scholar at Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA. Specializes in image-guided microwave/cryoablation therapy for lung cancer, liver cancer, renal cancer, bone and soft tissue tumors; superselective transcatheter arterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC); percutaneous arterial/venous pump or port implantation; radioactive seed implantation; percutaneous vertebroplasty; and stenting for tumor-induced stenosis or obstruction of the gastrointestinal tract, biliary tract, airway, and vena cava. Focuses on comprehensive tumor treatment with a distinctive approach to minimally invasive interventional therapy. Standing Committee Member, Committee of Tumor Ablation Therapy, Chinese Anti-Cancer Association Standing Committee Member, Committee of Tumor Interstitial Implantation, Chinese Anti-Cancer Association Standing Committee Member, Committee of Cryoablation and Targeted Therapy, National Strategic Alliance for Technological Innovation in Minimally Invasive Tumor Treatment Member, Committee of Tumor Interventional Therapy, Chinese Anti-Cancer Association Member, Liver Tumor Branch, China International Exchange and Promotive Association for Medical and Health Care Member, Interventional Combined Surgery Group, Beijing Medical Association Lead Author, "Clinical Practice Guidelines for Transcatheter Arterial Chemoembolization (TACE) in Hepatocellular Carcinoma in China (First Edition)" Lead Author, "Chinese Expert Consensus on Operational Standards for Hot and Cold Multimodal Ablation Therapy for Liver Malignancies and Lung Malignancies" First author of over 20 SCI-indexed and core Chinese journal publications; led and participated in multiple national and provincial research projects.